top of page

U.S. Biotech Investment Trend Q1 2026: Modalities

Ailin Zhang, Leah Kim, Alisa Peshina, Stuti Chakraborty

2026/05/21

U.S. Biotech Investment Trend Q1 2026: Modalities

  • This week, we examine the U.S. Biotech Investment Trends for Q1 2026, focusing on the shift in modalities and the explosive growth of AI-driven platforms. Is the "AI-first" approach the new gold standard for drug discovery? Check out the cards below for the full breakdown of the deals, players, and shifts defining the quarter.

  • Check out the full article here!

bottom of page